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The role of mitochondria in immune-
mediated disease: the dangers of a split
personality
David S. Pisetsky
Each cell in the body is endowed with a rich and diverse
set of organelles that perform the specialized activities
essential for cell survival and differentiated cell function.
These organelles can be defined by morphology as well
as biochemical composition, although the critical distin-
guishing feature is function. The exact number of these
organelles differs among cell types. Indeed, the appear-
ance of cells is, by and large, determined by the number
of organelles and their disposition within the confines of
the cell.
In the study of the cell, our colleagues in cell biology
and molecular biology have been very practical and nar-
rowly and precisely focused on the intracellular function
of organelles. In this utilitarian conceptualization, an or-
ganelle does not have a personality. It has a job. Immu-
nologists are a different breed, however, and go beyond
the intracellular space in analyzing the role of molecules
and structures. Importantly, immunologists know that
these entities can have a complex and shifting identity
that transcends the usual intracellular function.
As shown by seminal experiments stemming from the
enunciation of the danger hypothesis, it is now clear
that, depending on their location, molecules and organ-
elles can have very distinct personalities. These personal-
ities are often split and sometimes multiple. While
inside the cell these structures have one function, out-
side the cell, they can have another—often immunologic.
HMGB1 is the now classic example of this phenomenon.
A non-histone nuclear protein, HMGB1 mediates
chromosomal architecture and transcriptional regulation
inside the nucleus; when it gets outside the cell during
cell death or activation it can stimulate inflammation.
When it comes to organelles with dynamic personal-
ities, the mitochondrion is at the top of the list. These
structures overflow with personality. Mitochondria are
key to energy production but they are also a storehouse
of molecules to mediate cell death by apoptosis.
Mitochondria can change shape and number dramatic-
ally and are also prone to breakdown and disruption.
Furthermore, after millions and billions of years of evo-
lution, mitochondria have a serious identity problem.
Are they prokaryotes enjoying a cozy and symbiotic resi-
dence in eukaryotic cells? Or are they eukaryotic organ-
elles that have retained prokaryotic features to allow
better energy generation?
Mitochondria have long been viewed as endosymbi-
onts which may have evolved from alpha-proteobacteria.
The evolution has not been complete, however, and this
situation leads to an important role in immunology. As
has now been shown in both in vivo and in vitro sys-
tems, mitochondria have powerful immune activities
that relate to the molecular properties of key compo-
nents that resemble their bacterial counterparts. Thus,
mitochondria have their own DNA, a 16.5 K closed cir-
cle that differs from mammalian DNA in the status of
the CpG dinucleotides. Like bacterial DNA, mitochon-
drial DNA contains unmethylated CpG motifs that allow
stimulation of Toll-like (TLR) 9 receptor and likely other
internal nucleic acid sensors as well.
Boosting the immune activity of mitochondrial DNA
is the presence of 8-oxo-guanine residues. These resi-
dues arise from oxidative damage by reactive oxygen
species (ROS) and can occur in mitochondrial DNA
much more frequently than nuclear DNA. The proclivity
for these modifications may result from the proximity of
mitochondrial DNA to the electron transport system in
the interstices of the mitochondria. Furthermore, since
mitochondria DNA is not protected by histones, damage
from ROS may occur more readily.
Two other biochemical features may contribute to im-
mune potential. In mitochondria, protein synthesis starts
with a formylated amino acid just as in the case of bac-
teria. Formylated peptides can stimulate receptors on
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neutrophils to induce activation and chemotaxis. Another
mitochondrial protein called TFAM is also immunologic-
ally active. TFAM is structurally similar to HMGB1 and,
like its counterpart in the nucleus, TFAM can serve as an
alarmin and drive inflammation.
With cell stress, certain molecules can leave the mito-
chondria as permeability breaks down. Cytochrome c
can leave the mitochondrial sinking ship and interact
with other molecules to drive apoptosis. Similarly, mito-
chondrial DNA, once outside the confines of the mito-
chondria, can interact with internal sensors to activate
the inflammasome. With more severe cell dysfunction,
these mitochondrial products all leave the cell when the
cell dies.
In addition to leakage or release of individual compo-
nents, whole mitochondria can exit the cell to carry their
cargo of dangerous molecules. With stimulation of eo-
sinophils, exteriorization of whole mitochondria can
occur by a nifty mechanism called the mitochondrial
catapult. Another setting in which whole mitochondria
are present in an extracellular location is platelet activa-
tion. Among microparticles following platelet activation
are whole mitochondria as well as microparticles harbor-
ing mitochondria inside.
The presence of whole mitochondria in the extracellu-
lar space is remarkable, suggesting similarity to that
which occurs with bacteremia during an infection. This
situation has led to speculation that mitochondria are
important drivers of sterile inflammation and conditions
such as shock. In chronic autoimmune and inflamma-
tory disease, mitochondrial products can act systemically
as well as locally and contribute to the pathogenesis of
conditions like rheumatoid arthritis, where mitochon-
drial DNA in the joint can promote synovitis.
In view of the shifting personality of mitochondria and
their tendency to be downright dangerous, terminology is
evolving. On one hand, mitochondrial products are
DAMPs (damage-associated molecular patterns), since their
activity becomes manifest with cell death and damage. On
the other hand, these products can be considered PAMPs
(pathogen-associated molecular patterns) since their activ-
ities derive from some of the same molecular structures as
bacterial products. To avoid conflict and endless argument,
a more neutral and non-committal term may work: MAMP
or mitochondrial-associated molecular pattern.
The recognition of the mitochondrion’s immune power
adds another dimension to the emerging picture of the re-
purposing of molecules to drive innate immunity. While
an understanding of the role of mitochondria in immune
signaling is just beginning, the message is clear. Mitochon-
dria are unique in their biological split personality. Future
studies on autoimmune and inflammatory disease will
have to determine which aspect of this split is a source of
health and which a source of disorder.
Abbreviation
ROS, reactive oxygen species
Competing interests
The author declares that he has no competing interests.
Suggested Reading
1. Caielli S, Athale S, Domic B, Murat E, Chandra M, Banchereau R, et al.
Oxidized mitochondrial nucleoids released by neutrophils drive type I
interferon production in human lupus. J Exp Med. 2016;213(5):697–713.
2. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, et al. Quantitative
analysis of circulating mitochondrial DNA in plasma. Clin Chem. 2003;49(5):
719–26.
3. Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular
mitochondrial DNA and oxidatively damaged DNA in synovial fluid of
patients with rheumatoid arthritis. Arthritis Res Ther. 2003;5(5):R234–40.
4. Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin
driving autoimmune and inflammatory disease. Nat Rev Rheumatol.
2012;8(4):195–202.
5. Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, VanGundy ZC, et al.
Mitochondrial transcription factor A serves as a danger signal by
augmenting plasmacytoid dendritic cell responses to DNA. J Immunol.
2012;189(1):433–43.
6. Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK,
et al. Neutrophil extracellular traps enriched in oxidized mitochondrial
DNA are interferogenic and contribute to lupus-like disease. Nat Med.
2016;22(2):146–53.
7. Suter M, Richter C. Fragmented mitochondrial DNA is the predominant
carrier of oxidized DNA bases. Biochemistry. 1999;38(1):459–64.
8. Thrash JC, Boyd A, Huggett MJ, Grote J, Carini P, Yoder RJ, et al.
Phylogenomic evidence for a common ancestor of mitochondria and the
SAR11 clade. Sci Rep. 2011;1:13.
9. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al. Catapult-
like release of mitochondrial DNA by eosinophils contributes to antibacterial
defense. Nat Med. 2008;14(9):949–53.
10. Zhang Z, Meng P, Han Y, Shen C, Li B, Hakim MA, et al. Mitochondrial DNA-
LL-37 complex promotes atherosclerosis by escaping from autophagic
recognition. Immunity. 2015;43(6):1137–47.
Pisetsky Arthritis Research & Therapy  (2016) 18:169 Page 2 of 2
